| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.54 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.45 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.4 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.36 | 7e-08 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.36 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.31 | 4e-09 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.3 | 1e-05 |